CompletedNCT01795183
What is this study about?Researchers studied AMISULPRIDE to find out how it affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
In BeijingSchizophreniaMedication studyAges 18–65
- Countries
- China
- Sponsor
- Sanofi
CompletedNCT00338832
Official study titleAdapting a Physical Activity Intervention for Schizophrenia
This study has finished and is no longer accepting participants.
In La JollaSchizophreniaBehavioural studyAges 21–64
- Countries
- United States
- Sponsor
- Veterans Medical Research Foundation
CompletedNCT04542928
Official study titleEffectiveness of a Nurse Facilitated Face Care Group in Patients With Schizophrenia:A Randomized Controlled Trial
This study has finished and is no longer accepting participants.
In TaipeiSchizophreniaBehavioural studyAges 20+
- Countries
- Taiwan
- Sponsor
- National Yang Ming Chiao Tung University
CompletedNCT00312949
Official study titleConsumer Internet Education About Mental Health Quality
This study has finished and is no longer accepting participants.
In BaltimoreSchizophreniaBehavioural studyAges 13+
- Countries
- United States
- Sponsor
- Johns Hopkins Bloomberg School of Public Health
CompletedNCT00345033
Official study titleAripiprazole for Clozapine Associated Medical Morbidity
This study has finished and is no longer accepting participants.
In BostonSchizophreniaMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Massachusetts General Hospital (Hospital / academic medical center)
CompletedNCT03839251
This study has finished and is no longer accepting participants.
Multiple locations, including BusanSchizophreniaMedication studyAges 19–60
- Countries
- South Korea
- Sponsor
- Chonbuk National University Hospital
CompletedNCT07575516
What is this study about?This study evaluated the effectiveness of Ashwagandha for people with schizophrenia.
This study has finished and is no longer accepting participants.
In MakassarSchizophreniaMedication studyAges 20–45
- Countries
- Indonesia
- Sponsor
- Hasanuddin University
CompletedNCT01160679
Official study titleEffectiveness of Atypical Antipsychotics on Anhedonic Features in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including BusanSchizophreniaObservational studyAges 20+
- Countries
- South Korea
- Sponsor
- AstraZeneca
CompletedNCT00169065
Official study titleClozapine vs. Olanzapine: An Effectiveness Study
This study has finished and is no longer accepting participants.
In Jamaica PlainSchizophreniaMedication studyAges 20–60
- Countries
- United States
- Sponsor
- Harvard Medical School (HMS and HSDM)
CompletedNCT00940394
Official study titleEvaluation of the Effects of Mutual Support and Psycho-educational Group Interventions for Family Caregivers of People With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including ShatinSchizophreniaBehavioural studyAges 18–50
- Countries
- China
- Sponsor
- The Hong Kong Polytechnic University
CompletedNCT00158223
What is this study about?Researchers compared Pimozide and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including New YorkSchizophreniaMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Icahn School of Medicine at Mount Sinai
CompletedNCT00312962
Official study titleNeuroscience-Guided Remediation of Cognitive Deficits in Schizophrenia
This study has finished and is no longer accepting participants.
In San FranciscoSchizophreniaBehavioural studyAges 18–60
- Countries
- United States
- Sponsor
- University of California, San Francisco